Birdwatch Note Rating
2023-06-27 16:38:21 UTC - HELPFUL
Rated by Participant: 36B931EFE1FBBF6A4CA216D759CEB2A25E4BF273CD8DD941A462762D725D0FAE
Participant Details
Original Note:
Ketamine, an anesthetic used for many years, was sanctioned by the FDA in 2019 as a nasal spray for individuals suffering from depression that has been resistant to other treatments. Studies have shown it to be as effective as ECT at treating depression. Harvard Health https://www.health.harvard.edu/blog/ketamine-for-treatment-resistant-depression-when-and-where-is-it-safe-202208092797
All Note Details